- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04892316
Using Machine Learning to Adapt Visual Aids for Patients With Low Vision
According to the WHO's definition of visual impairment, as of 2018, there were approximately 1.3 billion people with visual impairment in the world, and only 10% of countries can provide assisting services for the rehabilitation of visual impairment. Although China is one of the countries that can provide rehabilitation services for patients with visual impairment, due to restrictions on the number of professionals in various regions, uneven diagnosis and treatment, and regional differences in economic conditions, not all visually impaired patients can get the rehabilitation of assisting device fitting.
Traditional statistical methods were not enough to solve the problem of intelligent fitting of assisting devices. At present, there are almost no intelligent fitting models of assisting devices in the world. Therefore, in order to allow more low-vision patients to receive accurate and rapid rehabilitation services, we conducted a cross-sectional study on the assisting devices fitting for low-vision patients in Fujian Province, China in the past five years, and at the same time constructed a machine learning model to intelligently predict the adaptation result of the basic assisting devices for low vision patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Jianmin Hu, M.D., Ph.D.
- Phone Number: +8615359595888
- Email: doctorhjm@163.com
Study Locations
-
-
Fujian
-
Quanzhou, Fujian, China, 362000
- Recruiting
- 2nd Affilliated Hospital of Fujian Medical University
-
Contact:
- Jianmin Hu, M.D., Ph.D.
- Phone Number: +8615359595888
- Email: doctorhjm@163.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Low vision
- Aged 3 to 105
Exclusion Criteria:
- Severe systemic disease
- Failure to sign informed consent or unwilling to participate
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Junior doctor group
Patients receive assisting devices fitting services from junior doctors
|
The training dataset was used to train the model, which was validated and tested by the other two datasets.
|
Senior doctor group
Patients receive assisting devices fitting services from senior doctors
|
The training dataset was used to train the model, which was validated and tested by the other two datasets.
|
Algorithm assisted group
Patients receive assisting devices fitting services from junior doctors assisted by the machine learning model
|
The training dataset was used to train the model, which was validated and tested by the other two datasets.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Accuracy of fitting results for assisting devices
Time Frame: baseline
|
The investigator will calculate the accuracy of fitting results for assisting devices in different group according to the ground truth.
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time cost for fitting assisting devices
Time Frame: baseline
|
The investigator will calculate time cost for fitting assisting devices in different group.
|
baseline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SFLV-2020
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Artificial Intelligence
-
Cairo UniversityRecruiting
-
Istituto Clinico HumanitasCompletedArtificial IntelligenceItaly
-
Istituto Clinico HumanitasRecruitingArtificial IntelligenceItaly
-
Istituto Clinico HumanitasCompletedArtificial IntelligenceItaly
-
Second Affiliated Hospital, School of Medicine,...UnknownArtificial IntelligenceChina
-
Cairo UniversityRecruitingArtificial IntelligenceEgypt
-
Qingdao UniversityUnknownCancer | Artificial IntelligenceChina
-
Renmin Hospital of Wuhan UniversityNot yet recruitingArtificial Intelligence | SurveillanceChina
-
Renmin Hospital of Wuhan UniversityNot yet recruitingArtificial Intelligence | ColonoscopyChina
Clinical Trials on Diagnostic test
-
Hospital Clínica KennedyCompletedStroke | Insomnia | Ischemic Heart Disease | Sleep-disordered Breathing | HypersomniaEcuador
-
Istanbul UniversityRecruitingCleft Lip and Palate | Dental Age EstimationTurkey
-
Hospices Civils de LyonRecruiting
-
Hospital St. Joseph, Marseille, FranceRecruiting
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Suleyman Demirel UniversityRecruiting
-
University of ZurichRecruiting
-
Institute of Cardiometabolism and Nutrition, FranceEnrolling by invitationInduced Pluripotent Stem CellsFrance
-
CDx DiagnosticsCompletedBarrett Esophagus | Esophageal Adenocarcinoma | Esophageal DysplasiaBelgium
-
ChroniSense Medical Ltd.Completed